Robert W. Baird initiated coverage on shares of Laboratory Corp. of America Holdings (NYSE: LH) in a research report sent to investors on Friday morning, AnalystRatingsNetwork.com reports. The firm issued a neutral rating and a $100.00 price target on the stock. The analysts noted that the move was a valuation call.
Laboratory Corp. of America Holdings (NYSE: LH) traded down 0.09% on Friday, hitting $97.25. Laboratory Corp. of America Holdings has a 1-year low of $82.15 and a 1-year high of $101.69. The stock’s 50-day moving average is currently $99.36. The company has a market cap of $9.035 billion and a price-to-earnings ratio of 16.46.
Other equities research analysts have also recently issued reports about the stock. Analysts at JPMorgan Chase & Co. reiterated a neutral rating on shares of Laboratory Corp. of America Holdings in a research note to investors on Thursday, July 11th. They now have a $95.00 price target on the stock. Separately, analysts at Mizuho raised their price target on shares of Laboratory Corp. of America Holdings from $92.00 to $97.00 in a research note to investors on Wednesday, July 10th. They now have a neutral rating on the stock. Finally, analysts at Canaccord Genuity raised their price target on shares of Laboratory Corp. of America Holdings from $101.00 to $115.00 in a research note to investors on Thursday, June 27th. They now have a buy rating on the stock.
Sixteen equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. The stock presently has an average rating of Hold and an average price target of $99.75.
Laboratory Corporation of America Holdings is a clinical laboratory company in the United States. Through a national network of laboratories, the Company offers a range of testing services used by the medical profession in routine testing, patient diagnosis, and in the monitoring and treatment of disease.